glycerol has been researched along with pioglitazone in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antoine, B; Beale, EG; Chauvet, G; Forest, C; Quette, J; Tordjman, J | 1 |
| Basu, A; Basu, R; Chandramouli, V; Cohen, O; Dicke, B; Landau, BR; Norby, B; Rizza, RA; Shah, P | 2 |
| Kazdová, L; Kurtz, TW; Maxová, M; Mlejnek, P; Pravenec, M; Simáková, M; Zídek, V | 1 |
| Buzzigoli, E; Casolaro, A; Ciociaro, D; Ferrannini, E; Frascerra, S; Gastaldelli, A; Nannipieri, M | 1 |
2 trial(s) available for glycerol and pioglitazone
| Article | Year |
|---|---|
Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes.
Topics: Blood Glucose; Body Mass Index; C-Peptide; Diabetes Mellitus, Type 2; Diet, Diabetic; Double-Blind Method; Drug Administration Schedule; Fatty Acids, Nonesterified; Female; Glucagon; Gluconeogenesis; Glucose Clamp Technique; Glycerol; Glycogenolysis; Humans; Hypoglycemic Agents; Infusions, Intravenous; Insulin; Kinetics; Liver; Male; Metformin; Middle Aged; Pioglitazone; Placebos; Thiazolidinediones | 2008 |
Decreased whole body lipolysis as a mechanism of the lipid-lowering effect of pioglitazone in type 2 diabetic patients.
Topics: Diabetes Mellitus, Type 2; Double-Blind Method; Fasting; Fatty Acids, Nonesterified; Female; Glycerol; Humans; Hypolipidemic Agents; Insulin; Lipolysis; Male; Middle Aged; Pioglitazone; Placebos; Thiazolidinediones; Triglycerides | 2009 |
3 other study(ies) available for glycerol and pioglitazone
| Article | Year |
|---|---|
Thiazolidinediones block fatty acid release by inducing glyceroneogenesis in fat cells.
Topics: Adipocytes; Adrenergic beta-Agonists; Animals; Cells, Cultured; Cyclic AMP; Enzyme Activation; Esterification; Fatty Acids; Female; Gene Expression; Glycerol; Glycerol Kinase; Homeostasis; Hypoglycemic Agents; Isoproterenol; Lipid Metabolism; Lipolysis; Phosphoenolpyruvate Carboxykinase (GTP); Pioglitazone; Pyruvic Acid; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Viscera | 2003 |
Effects of pioglitazone and metformin on NEFA-induced insulin resistance in type 2 diabetes.
Topics: Blood Glucose; Body Mass Index; C-Peptide; Diabetes Mellitus, Type 2; Fat Emulsions, Intravenous; Fatty Acids, Nonesterified; Female; Glucagon; Gluconeogenesis; Glucose; Glucose Clamp Technique; Glycerol; Heparin; Humans; Insulin; Insulin Resistance; Male; Metformin; Middle Aged; Pioglitazone; Thiazolidinediones | 2008 |
Long-term pioglitazone treatment enhances lipolysis in rat adipose tissue.
Topics: Adiponectin; Adipose Tissue; Animals; DNA, Mitochondrial; Fatty Acids, Nonesterified; Glycerol; Hypoglycemic Agents; Insulin; Lipolysis; Muscle, Skeletal; Palmitates; Pioglitazone; Rats; Rats, Inbred SHR; Thiazolidinediones; Triglycerides | 2008 |